Development and evaluation of a human skin equivalent in a semiautomatic microfluidic diffusion chamber

20Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

There is an increasing demand for transdermal transport measurements to optimize topical drug formulations and to achieve proper penetration profile of cosmetic ingredients. Reflecting ethical concerns the use of both human and animal tissues is becoming more restricted. Therefore, the focus of dermal research is shifting towards in vitro assays. In the current proof-of-concept study a three-layer skin equivalent using human HaCaT keratinocytes, an electrospun polycaprolactone mesh and a collagen-I gel was compared to human excised skin samples. We measured the permeability of the samples for 2% caffeine cream using a miniaturized dynamic diffusion cell (“skin-on-a-chip” microfluidic device). Caffeine delivery exhibits similar transport kinetics through the artificial skin and the human tissue: after a rapid rise, a long-lasting high concentration steady state develops. This is markedly distinct from the kinetics measured when using cell-free constructs, where a shorter release was observable. These results imply that both the established skin equivalent and the microfluidic diffusion chamber can serve as a suitable base for further development of more complex tissue substitutes.

Cite

CITATION STYLE

APA

Tárnoki-Zách, J., Mehes, E., Varga-Medveczky, Z., Isai, D. G., Barany, N., Bugyik, E., … Czirok, A. (2021). Development and evaluation of a human skin equivalent in a semiautomatic microfluidic diffusion chamber. Pharmaceutics, 13(6). https://doi.org/10.3390/pharmaceutics13060910

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free